It's money that matters: The financial context of ethical decision-making in modern biomedicine

Sociology of Health and Illness

Volumn 28, Issue 6, 2006, Pages 768-784

  Hedgecoe, Adam M ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

Bioethics; Herceptin; Pharmacogenetics; Rationing; Sociology

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MONOCLONAL ANTIBODY; TRASTUZUMAB;

ARTICLE; BIOETHICS; BIOSYNTHESIS; BREAST TUMOR; DECISION MAKING; DRUG APPROVAL; ECONOMICS; ETHICS; FEMALE; HEALTH PERSONNEL ATTITUDE; HUMAN; INTERVIEW; METABOLISM; PATIENT SELECTION; PHARMACOGENETICS; UNITED KINGDOM;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; ATTITUDE OF HEALTH PERSONNEL; BIOETHICS; BREAST NEOPLASMS; DECISION MAKING; DRUG APPROVAL; FEMALE; GREAT BRITAIN; HUMANS; INTERVIEWS; PATIENT SELECTION; PHARMACOGENETICS; RECEPTOR, ERBB-2;

EID: 33845886361     PISSN: 01419889     EISSN: 14679566     Source Type: Journal    
DOI: 10.1111/j.1467-9566.2006.00541.x     Document Type: Article

References (43)

1. Birch, S. and Gafni, A. (2002) On being NICE in the UK: guidelines for technology appraisal for the NHS in England and Wales, Health Economics, 11, 185-91.
2. Bloche, M.G. and Jacobson, P.D. (2000) The Supreme Court and bedside rationing, Journal of the American Medical Association, 284, 21, 2776-9.
3. Breast Cancer Care (2004) Press Statement: on HER2 testing and Herceptin.
4. Clark, J.A., Potter, D.A. and McKinlay, J.B. (1991) Bringing social structure back into clinical decision-making, Social Science and Medicine, 32, 8, 853-66.
5. Cooter, R. (2000) The ethical body. In Cooter, R. and Pickstone, J. (eds) Medicine in the Twentieth Century. Amsterdam: Harwood Academic Publishers.
6. Corrigan, O. (2003) Empty ethics: the problem with informed consent, Sociology Of Health and Illness, 25, 7, 768-92.
7. Daniels, N., Light, D. and Caplan, R.L. (1996) Benchmarks of fairness for health care reform. New York: Oxford University Press.
8. De Vries, R. (2004) A Pleasing Birth: Midwives and Maternity Care in the Netherlands. Philadelphia: Temple University Press.
9. Elder, A.T. and Fox, K.A.A. (1992) Thrombolytic treatment for elderly patients, British Medical Journal, 305, 846-7.
10. Fox, R.C. and Swazey, J.P. (1984) Medical morality is not bioethics - medical ethics in China and the United States, Perspective in Biology and Medicine, 27, 336-60.
11. Gray, B.H. (1975) Human Subjects in Medical Experimentation: a Sociological Study of the Conduct and Regulation of Clinical Research. New York: Wiley Intersci.
12. Hall, M.A. (1994) Rationing health care at the bedside, New York Unviersity Law Review, 69, 4-5, 693-780.
13. Harris, J. (1987) QALY fying the value of life, Journal of Medical Ethics, 13, 117-23.
14. Harris, J. (2005) It's not NICE to discriminate, Journal of Medical Ethics, 31, 373-5.
15. Harth, S.C. and Thong, Y.H. (1995) Parental perceptions and attitudes about informed consent in clinical research involving children, Social Science and Medicine, 41, 12, 1647-51.
16. Hedgecoe, A.M. (2004) The Politics of Personalised Medicine - Pharmacogenetics in the Clinic. Cambridge: Cambridge University Press.
17. Hedgecoe, A.M. (2005) 'At the point at which you can do something about it, then it becomes more relevant': informed consent in the pharmacogenetic clinic, Social Science and Medicine, 61, 6, 1201-10.
18. Hurst, S.A., Chandros Hull, S., DuVal, G. and Danis, M. (2005) Physicians' responses to resource constraints, Archives of Internal Medicine, 165, 639-44.
19. James, R.J. (2002) Commentary on Kewell, B., Hawkins, C. and Ferlie, E. (2002) Calman-Hine reassessed, Journal of Evaluation in Clinical Practice, 8, 3, 299-301.
20. Kewell, B., Hawkins, C. and Ferlie, E. (2002) Calman-Hine reassessed: a survey of cancer network development in England, 1999-2000, Journal of Evaluation in Clinical Practice, 8, 3, 303-11.
21. Khushf, G. (1999) The aesthetics of clinical judgement: exploring the link between diagnostic elegance and effective resource utilization, Medicine, Health Care and Philosophy, 2, 141-59.
22. th Edition. Harlow: Prentice Hall.
23. Klein, R., Day, P. and Redmayne, S. (1996) Managing Scarcity: Priority Setting and Rationing in the National Health Service. Buckingham: Open University Press.
24. Lidz, C.W., Meisel, A., Osterweis, M., Holden, J.L., Marx, J.H. and Munetz, M. (1983) Barriers to informed consent, Annals of Internal Medicine, 99, 539-43.
25. Light, D.W. and Hughes, D. (2001) Introduction: A sociological perspective on rationing: power, rhetoric and situated practices, Sociology of Health and Illness, 23, 5, 551-69.
26. McKinlay, J.B., Potter, D.A. and Feldman, H.A. (1996) Non-medical influences on medical decision-making, Social Science and Medicine, 42, 5, 769-76.
27. Meikle, J. (2005) Minister forces Herceptin U-turn, The Guardian, Thursday 10 November.
28. Mooney, G. (1989) QALYs: are they enough? A health economist's perspective, Journal of Medical Ethics, 15, 148-52.
29. National Institute for Clinical Excellence (2002) Guidance on the Use of Trastuzumab for the Treatment of Advanced Breast Cancer. London: National Institute for Clinical Excellence.
30. Newdick, C. (1995) Who Should We Treat?: Law, Patients and Resources in the NHS. Oxford: Clarendon Press.
31. Nuffield Council on Bioethics (2003) Pharmacogenetics: ethical issues. Report of Working Party. London: Nuffield Council on Bioethics.
32. Paul, J.E. and Trueman, P. (2001) Fourth hurdle reviews, NICE, and database applications, Pharmacoepidemiology and Drug Safety, 10, 429-38.
33. Pellegrino, E.D. and Thomasma, D. (1981) A Philosophical Basis of Medical Practice: Towards a Philosophy and Ethic of the Healing Professions. New York and Oxford: Oxford University Press.
34. Povar, G. and Moreno, J. (1988) Hippocrates and the health maintenance organization: a discussion of ethical issues, Annals of Internal Medicine, 109, 5, 419-24.
35. Prior, L. (2001) Rationing through risk assessment in clinical genetics: all categories have wheels, Sociology of Health and Illness, 23, 5, 570-93.
36. Rawles, J. (1989) Castigating QALYs, Journal of Medical Ethics, 15, 143-7.
37. Seedhouse, D.F. (1995) Why bioethicists have nothing useful to say about health care rationing, Journal of Medical Ethics, 21, 288-91.
38. Singer, P., McKie, J., Kuhse, H. and Richardson, J. (1995) Double jepoardy and the use of QALYs in health care allocation, Journal of Medical Ethics, 21, 144-150.
39. Ubel, P.A. and Goold, S. (1997) Recognizing bedside rationing: clear cases and tough calls, Annals of Internal Medicine, 126, 1, 74-80.
40. Varekamp, I., Krol, L.J. and Danse, J.A.C. (1998) Age rationing for renal transplantation? The role of age in decisions regarding scarce life extending medical resources, Social Science and Medicine, 47, 1, 113-20.
41. Weiner, S. (2001) 'I can't afford that!' Dilemmas in the care of the uninsured and underinsured, Journal of General Internal Medicine, 16, 6, 412-8.
42. Weinstein, M.C. (2001) Should physicians be the gatekeepers of resources? Journal of Medical Ethics, 27, 268-74.
43. Zussman, R. (1997) Sociological perspectives on medical ethics and decision-making, Annual Review of Sociology, 23, 171-89.